In May 2017, won the award of innovation award for the 2016 Shanghai Staff Proposals.
In June 2017,won the bronze award for the Outstanding Invention of Shanghai.
In January 2016, a new patent certificate was obtained for a roller cleaning device.
In February 2016, won the prize of the 2015 national Ankang Cup.
In April 2016, passed Malaysia PIC/S certification
In May 2016, the reselection of suppliers of EPO culture filter passed 2015 Shanghai Outstanding Proposals from Staff.
In November 2016, obtained the Certificate of High-tech Enterprise.
In 2015, won the title of Enterprise Technology Center of Jinshan district.
In June 2015, won the title of Shanghai Patent Pilot Enterprise.
In November 2015, won the third prize of science and technology progress award in Jinshan district.
In January 2014, awarded the GMP certificatefor frozen dry powder injection (anti-tumor medicine) and injection recombinanthuman progenin (CHO cell).
In August 2014, certified by the ministry of health of Colombia.
In September 2014, awarded the GMP certificate for Recombinanthuman for injection γ.
In April 2013, awarded the patent certificatefor the transdermal delivery system and preparation methods of drugs treatinghemorrhoids caused by enlarged or varicose veins in the subcutaneous vein ofthe anus.
In May 2013, awarded the invention patent certificate for an effective expression vector for the animal cells.
In August 2013, renewed the membership of Commodity Barcode System of China.
In October 2013, awarded the title of Advanced Workers Union of Putuo district from 2012 to 2013.
In October 2013, awarded the title of Shanghai Model Workers Union.
In May 2012, held the establishment meeting ofthe fifth party branch of Fosun Pharmaceutical (group).
In June 2012, held the second annual congressof the union of Chemo Wanbang.
In June 2012, the construction of a joint plantfor the recombinant protein drugs and pharmaceutical preparation and researchand development was completed.
In September 2012, obtained the Chemo Wanbang logo(9732592) (9732599) registration certificate.
In October 2012, obtained the patentcertificate for a synthetic signal peptide and its application.
In October 2012, the business license waspostponed and the paid-in capital changed to 153 million yuan RMB.
In November 2012, awarded the certificate of Shanghai Biomedical Industry Integrity Enterprise.
In December 2012, awarded the title of Shanghai Science and Technology Small Giant Enterprise.
In March 2011, Chemo Wanbang was certified by Cuba.
In 2011, R-SK workshop passed the review of GMPcertification.
In August 2011, certified by the ministry of health of Colombia.
In August 2011, signed a contract for the landuse rights of state-owned construction land with Jinshan Planning and Land Administration.
In August 2011, obtained trademark registrationcertificate for Eluzer.
In September 2011, held the founding ceremonyof the Jinshan new plant.
In October 2011, total investment increased by320 million yuan RMB, and registered capital increased to 153 million yuan RMB.
In January 2010, shares ownership changed (KelongBio transferred 70 % of its shares to Jiangsu Wanbang).
In February 2010, obtained the 5th classtrademark registration certificate for Eluzer.
In March 2010, obtained the National Key New Productcertificate forPemetrexedDisodium for Injection.
In April 2010, the legal representative of the companywas changed from Ii Xianlin to Zhou Yongchun.
In May 2010, Fosun Pharmaceutical signed astrategic cooperation framework agreement with CHEMO pharmaceutical group of Spain, and introduced four monoclonal antibody projects, which were producedand developed on the platform of Chemo Bio.
In August 2010, the recombinant humanerythropoietin and interferon r were reviewed by GMP
In September 2010, obtained the certificate of Shanghai High-tech Enterprise.
In September 2010, obtained the certificate of Shanghai Biomedical Industry Integrity Enterprise.
In September 2010, awarded the registration certificates of ALIMTA and EPO in Thailand and 2 other countries.
In September 2010, Jinshan project investment agreement was signed.
In February 2009, a board member was changed from Gustavo to Alain.
In February 2009, the drug production license of Kelong company was changed to Shanghai Chemo Wanbang Biopharma Co., LTD.
In May 2009, obtained Shanghai Statistics Registration certificate.
In May 2009, obtained the finance registration certificate of foreign invested enterprises.
In September 2009, the third board meeting washeld at the CHEMO headquarters in Madrid, Spain.
In January 2008, Kelong and Chemo group signedsino-foreign joint venture letter of intent.
In April 2008, Kelong signed a sino-foreignjoint venture contract with Kemai.
In October 2008, the Foreign Assets Commissionapproved the establishment of Shanghai Chemo Wanbang Biopharma Co., LTD.
In October 2008, obtained approval of foreigninvestment enterprise.
In November 2008, Shanghai Chemo Wanbang Biopharma Co., LTD wasestablished and the business license of enterprise legal person was obtained.
In November 2008, Li Xianlin was appointedchairman of the board and Zhou Yongchun as the CEO.
In November 2008, obtained the organizationcode certificate and tax registration certificate.